Acute myeloid leukemia (AML) is a heterogeneous group of genetically defined diseases.
Their classification is important with regard to prognosis and treatment. We performed …

Gene expression profiles were determined from presentation peripheral blood and bone
marrow samples of 28 patients with acute myeloid leukemia (AML). Hierarchical clustering …

Background In patients with acute myeloid leukemia (AML) a combination of methods must
be used to classify the disease, make therapeutic decisions, and determine the prognosis …

Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using
Microarray-Based Molecular Characterizatio Page 1 Disclosure of Candidate Genes in Acute …

Cytogenetic analysis is the most important diagnostic tool for determining prognosis in acute
myeloid leukemia (AML). In the majority of patients with AML, acquired clonal chromosome …

Balanced chromosomal rearrangements define distinct entities in acute myeloid leukemia
(AML). Here, we present 13 AML cases with t (8; 16)(p11; p13) with observed low incidence …

Acute myeloid leukemia (AML) is characterized by molecular heterogeneity. As commonly
altered genomic regions point to candidate genes involved in leukemogenesis, we used …

Over the last decades, significant advances have been made in the knowledge and
treatment of acute myeloid leukemia (AML). The WHO has recognized this new information …

Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized
by the accumulation of acquired somatic genetic alterations in hematopoietic progenitor …

Cytogenetic studies with high-resolution banding were performed on specimens from 132
consecutive patients with de novo acute myeloid leukemia (AML). All patients were treated …